Large-scale testing (Phase 3)Ended earlyNCT00394589What this trial is testingRe³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)Who this might be right forRheumatoid Arthritis Merck Sharp & Dohme LLC 43
Testing effectiveness (Phase 2)Study completedNCT00056797What this trial is testingTherapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIVWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 92
Large-scale testing (Phase 3)Active Not RecruitingNCT05677451What this trial is testing24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-upWho this might be right forChronic Spontaneous Urticaria Novartis Pharmaceuticals 100
Testing effectiveness (Phase 2)Study completedNCT01116141What this trial is testingCH-4051 in Patients With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis Chelsea Therapeutics 250
Not applicableNot Yet RecruitingNCT07829523What this trial is testingEffect of Aronia Supplementation on the LPS-CD14-TLR2/4 Axis in Football PlayersWho this might be right forExercise Training Hanna Dziewiecka 40
Early research (Phase 1)Study completedNCT00594373What this trial is testingInterventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected WomenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT02991859What this trial is testingPhase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic SubjectsWho this might be right forAsthma GlaxoSmithKline 56
Large-scale testing (Phase 3)Study completedNCT05169905What this trial is testingEvaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of AgeWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 9
Early research (Phase 1)Looking for participantsNCT07551037What this trial is testingEfficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance TherapyWho this might be right forAcute Myeloid LeukemiaPersonalized Active ImmunotherapyMaintenance Therapy Fujian Medical University Union Hospital 90
Large-scale testing (Phase 3)Study completedNCT00891020What this trial is testingTocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 886
Large-scale testing (Phase 3)UnknownNCT05090410What this trial is testingEfficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateWho this might be right forRheumatoid ArthritisJAK InhibitorIL-6 Inhibitor+2 more Atsushi Kawakami 400
Large-scale testing (Phase 3)Study completedNCT01063062What this trial is testingA Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 107
Large-scale testing (Phase 3)Ended earlyNCT01230827What this trial is testingThe Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)Who this might be right forJuvenile Idiopathic Arthritis Janssen Research & Development, LLC 173
Not applicableStudy completedNCT00001131What this trial is testingEffectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT07105722What this trial is testingA Trial to Evaluate the Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults 50 To 64 Years of AgeWho this might be right forPneumonia, Bacterial GlaxoSmithKline 127
Not applicableUnknownNCT03441997What this trial is testingThe Altered Immune Response to Exercise in Patients With Fibromyalgia Before and After a Mind-body InterventionWho this might be right forFibromyalgia University of Kansas Medical Center 40
Post-approval studies (Phase 4)Study completedNCT01000610What this trial is testingMabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 18
Testing effectiveness (Phase 2)Study completedNCT00031343What this trial is testingThe Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and RibavirinWho this might be right forHIV InfectionsHepatitis C National Institute of Allergy and Infectious Diseases (NIAID) 128
Early research (Phase 1)Study completedNCT00006325What this trial is testingSafety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive ChildrenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT01546818What this trial is testingSafety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected PatientsWho this might be right forHIV Infections Sumagen 33